Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Jurkat Cells
A CELL LINE derived from human T-CELL LEUKEMIA and used to determine the mechanism of differential susceptibility to anti-cancer drugs and radiation.
Year introduced: 1997
KM3413 [Supplementary Concept]
a mouse-human chimeric anti-Tn IgG1monoclonal antibody that induced anti-tumor activity against Jurkat cells in vitro and in vivo
Date introduced: October 10, 2008
apoptosis-induced regulator protein [Supplementary Concept]
a patented protein derived from a 3564 bp cDNA from okadaic acid-treated Jurkat cells; GenBank AX538681, AX538682, and AC538684
Date introduced: December 20, 2007
valparicine [Supplementary Concept]
from Kopsia arborea, showed pronounced cytotoxic effects against KB and Jurkat cells; structure in first source
Date introduced: October 2, 2007
aburatubolactam C [Supplementary Concept]
inhibits superoxide anionic generation in neutrophils; induces apoptosis in Jurkat T cells; isolated from Streptomyces; structure in first source
Date introduced: June 12, 1998
habiterpenol [Supplementary Concept]
abrogates bleomycin-induced G2 arrest in Jurkat cells; isolated from Phytohabitans suffuscus; structure in first source
Date introduced: January 20, 2015